A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C
一项旨在验证一种创新型超长效干扰素治疗慢性丙型肝炎的疗效和安全性的3期临床试验
期刊:JGH Open
影响因子:1.5
doi:10.1002/jgh3.12825
Chen, Chi-Yi; Chuang, Wan-Long; Qin, Albert; Zhang, Wen-Hua; Zhu, Li-Ying; Zhang, Guo-Qiang; Chen, Jyh-Jou; Lo, Ching-Chu; Zhou, Xinmin; Mao, Xiaorong; Shang, Jia; Kuo, Hsing-Tao; Xie, Wen; Chen, Chien-Hung; Lo, Gin-Ho; Jun, Dae W; Dang, Shuangsuo; Tsai, Chan-Yen; Wang, Ting-Fang; Lai, Hsin-Hui; Tseng, Kuan-Chiao; Huang, Yi-Wen; Chen, Pei-Jer